Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Heart-targeted amelioration of sepsis-induced myocardial dysfunction by microenvironment responsive nitric oxide nanogenerators in situ

Fig. 5

Specific cardiac targeting and delivery of PCM-MSN + LIFU in vivo. a Immunofluorescence study showing delivery efficiency of Cy5.5-stained MSN or PCM-MSN with or without LIFU to the heart at 6 h after individualized treatments. b Fluorescence intensity analysis after individualized treatments (n = 4). Data were presented as mean ± SD. *P < 0.05; **P < 0.01. c Accumulation of Cy5.5-stained PCM-MSN observed in the heart and other organs after LIFU irradiation. (d). Quantitation of merged fluorescence intensity in different organs (n = 4). Data were presented as mean ± SD. **P < 0.01

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us